Diagnosis

Osteosarcoma

The most common malignant bone tumor originating from primitive bone-forming mesenchymal cells.

Etiology

Cause [g5i]

Pathophysiology [g5i]

  1. Localization:

    • Primary: Near the growth plates of long bones (femur, tibia, humerus)

      Rapid bone growth during adolescence --> Increased risk of DNA mutation

    • Secondary: Skull, jaw, and pelvis, primarily the ilium

      Inflammation --> Increased risk of DNA mutation

  2. Sporadic mutation in the tumor suppressor genes

  3. Regulatory mechanisms become defective

  4. Uncontrolled cellular proliferation of a single clone of bone cells

  5. Osteosarcoma usually starts in osteoblasts

  6. Clinical presentation: bone pain, swelling, pathological fracture

Risk factors [g5i]

Complications [g5i]

Classification of bone tumors

Epidemiology

Incidence per 100.000 [g5i][sk6][gk6][d7u]

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

Arthralgia, Cough, Fever, Hemoptysis, Lymphadenopathy, Malaise, Night sweats

Clinical findings

Anemia, Bone lesion, Codmans triangle, Elevated CRP, Elevated Sedimentation Rate, Leukocytosis, Lytic bone lesion, Onion skin, Pathologic fracture, Permeative bone lesion, Sclerotic bone lesion, Sunray appearance

Anamneses

None listed.

Localized findings

Pain
Radiates
Bone (skeleton)JointsArmBackLower body
Onset
Gradual (days)
Pattern
Constant
Provoked by
Night
Quality
AchingDull
Severity
Mild (1-3)Moderate (4-7)
Swelling
Radiates
Bone (skeleton)
Onset
Gradual (days)
Pattern
Constant

Approach

Treatment

  1. Chemotherapy: [gk6]

    • Neoadjuvant (preoperative) --> Tumor shrinkage --> Facilitate surgical removal

    • Provide an important risk parameter

  2. Radiotherapy: Osteosarcomas are not particularly responsive to radiotherapy

  3. Surgery is the only option for definitive tumor removal [g5i]

    • Wide local excision

    • Limb-sparing surgery with allograft bone replacement or metallic prosthetics

    • Amputation

    • Rotationplasty

  4. Samarium: A radioactive drug that targets areas where bone cells are growing

  5. Targeted therapy: Drugs that block the action of specific enzymes, proteins, or other molecules involved in the growth of benign or malignant tumor cells

    • Kinase inhibitor

    • Mammalian target of rapamycin (mTOR) inhibitor [ree]

Differential diagnoses

Arthritis, Ewing sarcoma, Fracture, Langerhans cell histiocytosis, Lymphoma, Osteoblastoma, Osteoid osteoma, Osteomyelitis, Osteoperiostitis, Spinal disc herniation


References

[1] Greenwood AC, Arora RD, Shaikh H. Osteosarcoma (Osteogenic Sarcoma) [Updated 2024 Dec 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK563177/

[2] Grimer et al. UK Guidelines for the Management of Bone Sarcomas. Sarcoma. 2010;2010:317462.

[3] https://emedicine.medscape.com/article/1256857

[4] Mirabello et al. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer. 2009 Apr 1;115(7):1531-43.

[5] Rathore R, Van Tine BA. Pathogenesis and Current Treatment of Osteosarcoma: Perspectives for Future Therapies. J Clin Med. 2021 Mar 12;10(6):1182.

[6] Balmant et al. Incidence and mortality of bone cancer among children, adolescents and young adults of Brazil. Clinics (Sao Paulo). 2019 May 13;74:e858.

Scroll to top